Cardiovascular Systems Inc 4

Accession 0000914190-13-000819

CIK 0001180145operating

Filed

Nov 11, 7:00 PM ET

Accepted

Nov 12, 4:11 PM ET

Size

27.8 KB

Accession

0000914190-13-000819

Form 4

Period: 2013-11-07

Director

Transactions

Exercise of In-Money
Common Stock
2013-11-07$8.83/sh+151,617$1,338,778→ 211,177 total(indirect: Easton Hunt Capital Partners, L.P.)
Sale
Common Stock
2013-11-07$29.71/sh−45,065$1,338,881→ 527,575 total(indirect: Easton Capital Partners, LP)
Sale
Common Stock
2013-11-07$29.71/sh−45,065$1,338,881→ 166,112 total(indirect: Easton Hunt Capital Partners, L.P.)
Exercise of In-Money
Common Stock
2013-11-07$8.83/sh+151,617$1,338,778→ 572,640 total(indirect: Easton Capital Partners, LP)
Exercise of In-Money
Warrant (Right to Buy)
2013-11-07−151,617→ 0 total(indirect: Easton Capital Partners, LP)
Exercise: $8.83From: 2009-02-25Exp: 2014-02-24→ Common Stock (151,617 underlying)
Exercise of In-Money
Warrant (Right to Buy)
2013-11-07−151,617→ 0 total(indirect: Easton Hunt Capital Partners, L.P.)
Exercise: $8.83From: 2009-02-25Exp: 2014-02-24→ Common Stock (151,617 underlying)

Holdings

Stock Option (right to buy)
Exercise: $11.38Exp: 2017-11-12→ Common Stock (15,088 underlying)
15,088
Common Stock
8,000
Stock Option (right to buy)
Exercise: $7.90Exp: 2017-10-08→ Common Stock (4,321 underlying)
4,321
Restricted Stock Units
→ Common Stock (5,714 underlying)
5,714
Restricted Stock Units
→ Common Stock (11,628 underlying)
11,628
Restricted Stock Units
→ Common Stock (21,739 underlying)
21,739
Restricted Stock Units
→ Common Stock (10,917 underlying)
10,917
Restricted Stock Units
→ Common Stock (4,580 underlying)
4,580
Stock Option (right to buy)
Exercise: $8.83Exp: 2016-08-14→ Common Stock (38,820 underlying)
38,820
Restricted Stock Units
→ Common Stock (7,192 underlying)
7,192

Footnotes (6)

[F1]Mr. Friedman disclaims beneficial ownership of shares held by Easton Capital Partners, LP except to the extent of his pecuniary interest therein.
[F2]On November 7, 2013, the reporting person exercised two warrants, each to purchase 151,617 shares of Cardiovascular Systems, Inc. ("CSI") common stock for $8.83 a share. The reporting person paid the exercise price for each warrant on a cashless basis, resulting in CSI's withholding of 45,065 of the warrant shares of each warrant to pay the exercise price and issuing to the reporting person the remaining 106,552 shares of each warrant.
[F3]Mr. Friedman disclaims beneficial ownership of shares held by Easton Hunt Capital Partners, L.P. except to the extent of his pecuniary interest therein.
[F4]Fully exercisable.
[F5]Each restricted stock unit represents the right to receive a payment from CSI equal in value to the market price per share of CSI common stock on the date of payment and shall be payable in cash or shares of the Company's Common Stock beginning six months following the termination of each director's board membership.
[F6]Mr. Friedman disclaims beneficial ownership of warrants held by Easton Hunt Capital Partners, L.P. and Easton Capital Partners, LP except to the extent of his pecuniary interest therein.

Documents

1 file

Cardiovascular Systems Inc

CIK 0001180145

Entity typeoperating

IncorporatedDE